World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: TCTR
Last refreshed on: 29 April 2024
Main ID:  TCTR20160125003
Date of registration: 25/01/2016
Prospective Registration: No
Primary sponsor: Sabzevar University Medical Sc
Public title: Effect of topical application of Nigella sativa oil and oral acetaminophen on pain in elderly with knee Osteoarthritis in Clinical Trials
Scientific title: Effect of topical application of Nigella sativa oil and oral acetaminophen on pain in elderly with knee Osteoarthritis in Clinical Trials
Date of first enrolment: 19/01/2014
Target sample size: 40
Recruitment status: Enrolling by invitation
URL:  https://www.thaiclinicaltrials.org/show/TCTR20160125003
Study type:  Interventional
Study design:   
Phase:  Phase 1/Phase 2
Countries of recruitment
IRAN
Contacts
Name: akram    kooshki
Address:  Sabzevar university of Medical Sciences, Sabzevar, Iran 9613873136 IRAN Sabzevar university of Medical Sciences, Sabzevar, Iran
Telephone: +989159701470
Email: akooshki.nutr@yahoo.com
Affiliation:  sabzevar university medical sci
Name: maryam    mohammadi
Address:  Sabzevar university of Medical Sciences, Sabzevar, Iran 9613873136 ES Iran
Telephone: +989159701470
Email: akooshki.nutr@yahoo.com
Affiliation:  Shaheed Beheshti Medical sci
Key inclusion & exclusion criteria
Inclusion criteria: Age over 65 years, diagnosis of knee osteoarthritis according to American College Rheumatology diagnostic criteria including: 1) knee pain on most days of last month, 2) crepitus (joint sound in active motion). 3) Morning stiffness less than 30 minutes. 4) aged 45 to 60 years, 5) inflation in the examination of the knee bone, respectively (13), knee osteoarthritis confirmed by a physician, and the use of radiography, knee pain in the past 24 hours, so that the average linear measure - visual pain (VAS: Visual Analogue Score) is between 4-7 cm,
Exclusion criteria: lack of inflammatory diseases, metabolic disorders (diabetes), cancer or malignant diseases, symptoms or a history of liver or kidney failure, treatment with oral corticosteroids in the past 4 weeks or injection in the last 6 months, no fever, lack of sensitivity and allergy Nigella sativa oil, not wanting to continue to participate in the study, supplementation with vitamin - mineral or other nutritional supplements painkillers were the exit standards of the study.

Age minimum: 65 Years
Age maximum: 85 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Elderly; Nigella sativa oil; Pain; Osteoarthritis
Background: There is limited evidence to support the Nigella sativa's role as an effective complementary and alternative medicine and the anti-inflammatory effects of Nigella sativa on patients with a
Elderly; Nigella sativa oil; Pain; Osteoarthritis
Intervention(s)
Primary Outcome(s)
Effect of topical application of Nigella sativa oil and oral 2015 Pain was determined using visual scale (VAS)
Secondary Outcome(s)
Effect of topical application of Nigella sativa oil and oral 2015 Pain was determined using visual scale (VAS)
Secondary ID(s)
Source(s) of Monetary Support
Sabzevar University Medical Sc
Secondary Sponsor(s)
Sabzevar University Medical Sc
Ethics review
Status:
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed: 19/01/2015
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history